Susceptibility to a Dexamethasone Intraocular Implant with and Without Concomitant Oral Steroid Intake: A Case Report
暂无分享,去创建一个
[1] P. Mitchell,et al. Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. , 2012, Ophthalmology.
[2] F. Bandello,et al. Dexamethasone Intravitreal Implant In Patients With Refractory Diabetic Macular Edema , 2012 .
[3] M. Blumenkranz,et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. , 2011, Ophthalmology.
[4] S. Siddique,et al. Road to remission: a comprehensive review of therapy in uveitis , 2011, Expert opinion on investigational drugs.
[5] C. Lowder,et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. , 2011, Archives of ophthalmology.
[6] Jane S. Myung,et al. Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant , 2010, Clinical ophthalmology.
[7] M. Blumenkranz,et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. , 2010, Ophthalmology.
[8] George A. Williams,et al. Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. , 2010, Archives of ophthalmology.
[9] George A. Williams,et al. Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. , 2009, American journal of ophthalmology.